Cigarette Smoking and Adenocarcinomas of the Esophagus and Esophagogastric Junction: a Pooled Analysis from the International BEACON Consortium
Overview
Authors
Affiliations
Background: Previous studies that showed an association between smoking and adenocarcinomas of the esophagus and esophagogastric junction were limited in their ability to assess differences by tumor site, sex, dose-response, and duration of cigarette smoking cessation.
Methods: We used primary data from 10 population-based case-control studies and two cohort studies from the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Analyses were restricted to white non-Hispanic men and women. Patients were classified as having esophageal adenocarcinoma (n = 1540), esophagogastric junctional adenocarcinoma (n = 1450), or a combination of both (all adenocarcinoma; n = 2990). Control subjects (n = 9453) were population based. Associations between pack-years of cigarette smoking and risks of adenocarcinomas were assessed, as well as their potential modification by sex and duration of smoking cessation. Study-specific odds ratios (ORs) estimated using multivariable logistic regression models, adjusted for age, sex, body mass index, education, and gastroesophageal reflux, were pooled using a meta-analytic methodology to generate summary odds ratios. All statistical tests were two-sided.
Results: The summary odds ratios demonstrated strong associations between cigarette smoking and esophageal adenocarcinoma (OR = 1.96, 95% confidence interval [CI] = 1.64 to 2.34), esophagogastric junctional adenocarcinoma (OR = 2.18, 95% CI = 1.84 to 2.58), and all adenocarcinoma (OR = 2.08, 95% CI = 1.83 to 2.37). In addition, there was a strong dose-response association between pack-years of cigarette smoking and each outcome (P < .001). Compared with current smokers, longer smoking cessation was associated with a decreased risk of all adenocarcinoma after adjusting for pack-years (<10 years of smoking cessation: OR = 0.82, 95% CI = 0.60 to 1.13; and > or =10 years of smoking cessation: OR = 0.71, 95% CI = 0.56 to 0.89). Sex-specific summary odds ratios were similar.
Conclusions: Cigarette smoking is associated with increased risks of adenocarcinomas of the esophagus and esophagogastric junction in white men and women; compared with current smoking, smoking cessation was associated with reduced risks.
Sato S, Ohata E, Nakatani E, Hawke P, Sasaki H, Nagai E PLoS One. 2025; 20(2):e0318791.
PMID: 39932963 PMC: 11813134. DOI: 10.1371/journal.pone.0318791.
Ren Z, Kang M, Zhu L, Li P World J Gastrointest Surg. 2024; 16(12):3772-3779.
PMID: 39734461 PMC: 11650227. DOI: 10.4240/wjgs.v16.i12.3772.
Jin Z, Liu K, Wallar G, Zhou J, Mu L, Liu X Int J Cancer. 2024; 156(8):1552-1562.
PMID: 39552259 PMC: 11826109. DOI: 10.1002/ijc.35254.
Matsueda K, Manabe N, Watanabe T, Sato Y, Mizuno M, Haruma K BMC Gastroenterol. 2024; 24(1):342.
PMID: 39354388 PMC: 11443624. DOI: 10.1186/s12876-024-03421-6.
Gastrointestinal Cancer Therapy and Cardiotoxicity.
Leiva O, El Zarif T, Alvarez-Cardona J Curr Treat Options Oncol. 2024; 25(9):1203-1209.
PMID: 39102169 DOI: 10.1007/s11864-024-01236-x.